Kailera Therapeutics is trading 4.02% up at $17.07 after gaining 6.56% during the September 1, 2026 regular session and rebounding from recent declines.
- No verified September 2 company-specific announcement, earnings release, or major catalyst was found.
- The investor-relations page lists its latest financial-results release on August 12.
- Broader U.S. futures were modestly lower, offering no clear market-wide explanation for the upside.